Longitudinal micro-endoscopic monitoring of high-success intramucosal xenografts for mouse models of colorectal cancer

Int J Med Sci. 2019 Sep 20;16(11):1453-1460. doi: 10.7150/ijms.35666. eCollection 2019.

Abstract

Colorectal cancer (CRC) is one of the most frequently lethal forms of cancer. Intramucosal injection allows development of better mouse models of CRC, as orthotopic xenografts allow development of adenocarcinoma in the submucosa of the mouse colon wall. In this paper, a method of orthotopic injection is monitored longitudinally using cellular-resolution real-time in vivo fluorescence microendoscopy, following the injection of three different cell lines: 3T3-GFP to confirm immunosuppression and HCT116-RFP cells to model CRC. Adenoma formation is first observable after 7 to 10 days, and by use of 33 G needles a tumor induction rate of greater than 85% is documented. An additional experiment on the injection of rapamycin reveals drug efficacy and localization between 24 and 48 hours, and suggests the promise of real-time cellular-resolution fluorescence micro-endoscopy for developing longitudinal therapy regimes in mural models of CRC.

Keywords: Colorectal cancer; Orthotopic injection; fluorescence imaging; microendoscopy; mouse models; side-view endoscopy.

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenoma / pathology*
  • Animals
  • Colon / pathology
  • Colorectal Neoplasms / pathology*
  • Disease Models, Animal
  • HCT116 Cells
  • Heterografts / pathology*
  • Humans
  • Mice